+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Role of Arachidonic Acid or Its Metabolites in Growth-Hormone-Releasing Factor-Induced Release of Somatostatin from the Median Eminence

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The possible involvement of arachidonic acid (AA) release in growth-hormone-releasing factor (GRF)-induced somatostatin (SRIF) release from the median eminence (ME) of the hypothalamus was evaluated in adult male rats using an in vitro incubation system. The MEs were preincubated with [<sup>14</sup>C]-AA, then washed and incubated with vehicle or test agents, and the release of SRIF and [<sup>14</sup>C]-AA into the medium was measured. In the experiments designed only to determine SRIF release, the MEs were first preincubated for 30 min. The medium was then discarded and replaced with fresh buffer or test substances and incubated for 10, 20 and/or 30 min. GRF (10<sup>–10</sup> M) stimulated both AA and SRIF release significantly within 20 min, with maximum release occurring at 30 min. The stimulatory effect of GRF on AA release was coincident with the release of SRIF. A phospholipase A<sub>2</sub> inhibitor (10<sup>–6</sup> M, quinacrine) completely abolished the stimulatory effect of GRF on both AA and SRIF release. The release of SRIF induced by GRF was also inhibited by both indomethacin (10<sup>–6</sup> M, a cyclooxygenase inhibitor) and metyrapone (10-<sup>6</sup> M, a cytochrome P-450 inhibitor). On the other hand, nordihydroguaiaretic acid (10<sup>–6</sup> M, a lipoxygenase inhibitor) had no effect on GRF-evoked SRIF release. The data presented here suggest that an important GRF-mediated event leading to SRIF secretion is an elevated release of AA from ME fragments in vitro. In conclusion, our data are suggestive that the stimulatory effect of GRF on SRIF release is due, in part, to the release and subsequent metabolism of AA to one or more metabolites.

          Related collections

          Author and article information

          S. Karger AG
          03 April 2008
          : 52
          : 3
          : 238-242
          aDepartment of Physiology, Neuropeptide Division, The University of Texas Southwestern Medical Center at Dallas, Tex., USA; bInstitute of Molecular Biology, Endocrinology-090, Boris Kidric Institute, Belgrad, Yugoslavia; cDepartment of Obstetrics and Gynecology, University of Iowa, MRF, Iowa City, Iowa, USA
          125592 Neuroendocrinology 1990;52:238–242
          © 1990 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 5
          Original Paper


          Comment on this article